Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2024Dermatology and TherapyOpen Access

Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)

View Full Paper
Ask AI
Bookmark
Share

Authors

MVMario ValentiLGLuigi GargiuloLILuciano Ibba

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Valenti et al. (2024) studied this question.

synapsesocial.com/papers/68e69ff0b6db643587623400https://doi.org/10.1007/s13555-024-01182-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study2024 · 15 citations
  2. 2Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study2019 · 43 citations
  3. 3Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)2023 · 30 citations
  4. 4Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years2023 · 23 citations
  5. 5EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations2020 · 419 citations